Leishmania donovani (LD) is a protozoan species that causes visceral leishmaniasis. This species is common in Southern Europe, the Middle East and Central Asia. It is also found in India and China. LD is the causative agent of visceral leishmaniasis, which is one of the most severe forms of leishmaniasis.
LD has several clinical manifestations. The most common is the visceral form, which manifests itself as fever, weakness, abdominal and liver pain. Other forms include the cutaneous form, the ocular form, and the neural form.
Diagnosis of LD is based on blood tests and tissue biopsies. Treatment includes the use of antimalarial drugs such as chloroquine or mefloquine. However, treatment can be complex and requires constant monitoring by a doctor.
Visceral leishmaniasis is a serious health problem in some regions of the world. Its spread is associated with climate change and increased human migration. Therefore, controlling the spread of LD and preventing this disease are important public health goals.
Leishmania donovanii is a species of protozoan, genus L. It is widespread in Southern Europe (Italy, Spain, Greece), the Middle East (Syria, Iraq), Central Asia (Kazakhstan, Tajikistan, Uzbekistan), India and China. Leishmania donAvani is named after DonovAn, a famous Italian parasitologist and microbiologist.
Leishmania donovani is the causative agent of the visceral form of leishmaniasis. Visceral leishmaniasis is a chronic infectious disease caused by a parasite of the genus Leishmania. It is characterized by disruption of the immune system, tissues and organs, as well as inflammatory processes.
The causative agent of the disease lives in the victim’s body for several months or even years, causing various